578 related articles for article (PubMed ID: 19201002)
1. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
Chard D; Miller D
J Neurol Sci; 2009 Jul; 282(1-2):5-11. PubMed ID: 19201002
[TBL] [Abstract][Full Text] [Related]
2. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
3. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
4. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
Zivadinov R; Minagar A
J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
[TBL] [Abstract][Full Text] [Related]
5. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
6. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
[TBL] [Abstract][Full Text] [Related]
7. Gray matter pathology in (chronic) MS: modern views on an early observation.
Geurts JJ; Stys PK; Minagar A; Amor S; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):12-20. PubMed ID: 19249061
[TBL] [Abstract][Full Text] [Related]
8. Gray matter involvement in multiple sclerosis.
Pirko I; Lucchinetti CF; Sriram S; Bakshi R
Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
[TBL] [Abstract][Full Text] [Related]
9. Focal thinning of the cerebral cortex in multiple sclerosis.
Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
[TBL] [Abstract][Full Text] [Related]
10. Visualizing the cause of gray matter atrophy in multiple sclerosis.
Richert ND; Kraft E; Stüve O
Arch Neurol; 2009 Feb; 66(2):159-60. PubMed ID: 19204151
[No Abstract] [Full Text] [Related]
11. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
[TBL] [Abstract][Full Text] [Related]
12. Tourettism in multiple sclerosis: a case report.
Nociti V; Fasano A; Bentivoglio AR; Frisullo G; Tartaglione T; Tonali PA; Batocchi AP
J Neurol Sci; 2009 Dec; 287(1-2):288-90. PubMed ID: 19695578
[TBL] [Abstract][Full Text] [Related]
13. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
[TBL] [Abstract][Full Text] [Related]
14. Rate of brain atrophy in benign vs early multiple sclerosis.
Gauthier SA; Berger AM; Liptak Z; Duan Y; Egorova S; Buckle GJ; Glanz BI; Khoury SJ; Bakshi R; Weiner HL; Guttmann CR
Arch Neurol; 2009 Feb; 66(2):234-7. PubMed ID: 19204160
[TBL] [Abstract][Full Text] [Related]
15. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
[TBL] [Abstract][Full Text] [Related]
16. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
[TBL] [Abstract][Full Text] [Related]
17. Cortical pathology and cognitive impairment in multiple sclerosis.
Calabrese M; Rinaldi F; Grossi P; Gallo P
Expert Rev Neurother; 2011 Mar; 11(3):425-32. PubMed ID: 21375447
[TBL] [Abstract][Full Text] [Related]
18. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
19. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
20. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Lassmann H
Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
